Joakim Weidemanis - Jan 31, 2022 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Signature
/s/ James F. O'Reilly as attorney-in-fact for Joakim Weidemanis
Stock symbol
DHR
Transactions as of
Jan 31, 2022
Transactions value $
-$6,175,705
Form type
4
Date filed
2/2/2022, 04:04 PM
Previous filing
Jan 31, 2022
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DHR Common Stock Options Exercise $946K +20.5K +32.12% $46.13 84.4K Jan 31, 2022 Direct
transaction DHR Common Stock Sale -$5.85M -20.5K -24.31% $285.24 63.8K Jan 31, 2022 Direct F1
transaction DHR Common Stock Tax liability -$1.44M -5.01K -7.85% $287.29 58.8K Feb 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Employee stock option (right to buy) Options Exercise $0 -20.5K -100% $0.00* 0 Jan 31, 2022 Common Stock 20.5K $46.13 Direct F3
transaction DHR Danaher Deferred Compensation Programs - Danaher Stock Fund Award $168K +512 +3.98% $329.01 13.4K Feb 1, 2022 Common Stock 512 $0.00 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.060 to $285.350, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F2 This transaction relates to the withholding of certain shares for tax purposes in connection with the distribution of performance-based restricted stock units.
F3 One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was February 21, 2013.
F4 Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account.
F5 The notional shares convert on a one-for-one basis.
F6 The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.